18.1 C
Delhi
Wednesday, October 27, 2021

COVID-19 Vaccine updates: 3 major updates on Corona vaccine from India, China and Pakistan

 

Coronavirus Vaccine News: Scientists are working day and night to develop the novel Coronavirus Covid-19 vaccine in India. Meanwhile, the good news is that phase-3 trial of one of the three vaccines underway in India is going to start tomorrow. NITI Aayog member VK Paul gave this information on Tuesday. Paul told that the other two vaccines are in phase-1 and phase-2 trial. Let me tell you, Prime Minister Narendra Modi while addressing the nation on Independence Day, told that work is going on on three vaccines in India. On the other hand, a Chinese company has announced to launch the Corona vaccine commercially by the end of this year. Whereas, in Pakistan too, the drug regulator has approved the introduction of phase 3 trial of a vaccine developed by the Chinese company.

19.70 lakh patient recovery in India

Union Health Ministry Secretary Rajesh Bhushan said that the patients recovered from COVID 19 are more than 19.70 lakh. This is 2.93 times in active cases. The death rate has come down from 2 per cent since COVID 19. Bhushan said that if we talk about testing, then the testing is being increased continuously in the country. Over 8,99,000 tests were done in the last 24 hours.

The vaccine will reach every Indian

While addressing the nation on Independence Day, PM Modi said that our scientists are working hard towards making the vaccine. Work on 3 vaccines is going on in India, whose clinical trial is in different stages. A green signal is awaited from the scientists in this regard. After which they will start mass production. With production, the outline of how the vaccine reaches every Indian in the shortest time is also ready.

Amit Shah Hospitalized: Home Minister Amit Shah admitted to AIIMS for Post Covid Care

The Chinese company claims – Vaccine until the end of the year

Meanwhile, a major Chinese pharmaceutical company in China has said that Corona’s vaccine will be commercially available by the end of this year. Sinopharma chairman Liu Jinzhen told a Chinese Communist Party citation that the vaccine would cost less than 1000 yuan ($ 140). It will have to take two shots. Liu says that students and workers living in big cities will need to take the vaccine. People living in sparsely populated rural areas will not need it. Let me tell you, Sinopharma is working on two vaccines and its manufacturing capacity is 22 crore doses annually.

Phase-3 trial approved in Pakistan too

Pakistan’s drug regulator has also approved a phase-3 clinical trial of a COVID 19 vaccine. In the media report on Tuesday, it has been said that work is on to develop this vaccine in collaboration with a Chinese company. According to a statement from the National Institutes of Health (NIH), Pakistan’s drug regulator has approved phase-3 clinical trials of the coronavirus vaccine Adenovirus Type 5 vector (Ad5-nCoV). This vaccine has been developed by the Cansinobio and the Beijing Institute of Biotechnology China (BIB). For this, AJM Pharma of Pakistan has entered into an agreement.

(Input: ANI, PTI, AP)

Shehnazhttps://www.businesskhabar.com/
Shehnaz is a Corporate Communications Expert by profession and writer by Passion. She has experience of many years in the same. Her educational background in Mass communication has given her a broad base from which to approach many topics. She enjoys writing about Public relations, Corporate communications, travel, entrepreneurship, insurance, and finance among others.
Latest news
- Advertisement -
Related news
- Advertisement -

LEAVE A REPLY

Please enter your comment!
Please enter your name here